Your email has been successfully added to our mailing list.

×
0 -0.0103839988849397 -0.00341487211652376 0.00494808000557528 -0.0138685622691477 -0.0438358073733361 -0.0438358073733361 -0.0438358073733361
Stock impact report

Evolus: Is The Botox Knock Off Finally Here? [Seeking Alpha]

Evolus, Inc. (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
Company Research Source: Seeking Alpha
Evolus: Is The Botox Knock Off Finally Here?SummaryEOLS spiked Monday ahead of an FDA decision pursuant to a PDUFA for its botulinum toxin DWP-450.The FDA issued a Form 483 with 10 observations after a pre-approval inspection of the plant producing the treatment.There's no guarantee EOLS will receive a positive decision from the FDA, but it could give feedback on next steps.AGN's Botox controls the U.S. botulinum toxin market. Any threat from EOLS could punish AGN.I rate EOLS a hold and AGN a sell ahead of Tuesday's PDUFA outcome. Show less Read more
Impact Snapshot
Event Time:
EOLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for EOLS alerts
Opt-in for
EOLS alerts

from News Quantified
Opt-in for
EOLS alerts

from News Quantified